PG
DPLO

PEAK6 Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

PEAK6 Group’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-17,212
Closed -$401K – 5256
2018
Q1 		$347K Buy
17,212
+6,103
+55% +$142K ﹤0.01% 2922
2017
Q4 		$223K Sell
11,109
-21,724
-66% -$427K ﹤0.01% 3082
2017
Q3 		$680K Buy
+32,833
New +$555K ﹤0.01% 2291
2015
Q4 		– Sell
-8,023
Closed -$250K – 5567
2015
Q3 		$231K Buy
+8,023
New +$343K ﹤0.01% 3611

Other funds holding DPLO

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

PEAK6 Group's DPLO Position: Q2 2018 in Review

PEAK6 Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q2 2018, closing a stake of 17,212 shares — an estimated $401K sold.

PEAK6 Group first reported a position in DPLO in Q3 2015 and held it in 4 quarters. The position peaked at $680K in Q3 2017. 206 funds tracked by Wall St. Rank hold DPLO as of Q2 2018.

  • PEAK6 Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 17,212 DIPLOMAT PHARMACY, INC. shares in Q2 2018, an estimated $401K.
  • PEAK6 Group first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2015 and held it in 4 quarters.
  • PEAK6 Group's DIPLOMAT PHARMACY, INC. position peaked at $680K in Q3 2017.
  • 206 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.